Absci Corp
NASDAQ:ABSI
Absci Corp
NASDAQ:ABSI
Price:
4.91 USD
-4.47%
Market Closed
Updated:
May 11, 2024
Section:
Relative Value
The Relative Value of one
ABSI
stock under the Base Case scenario is
1.97
USD.
Compared to the current market price of 4.91 USD,
Absci Corp
is
Overvalued by 60%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ABSI
Relative Value
Base Case
1.97
USD
Overvaluation 60%
Valuation Multiples
Multiples Across Competitors
ABSI Competitors Multiples
Absci Corp Competitors
Absci Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Absci Corp
NASDAQ:ABSI
|
553.8m USD | 96.8 | -5 | -5.7 | -4.9 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
229.3B USD | 5.4 | 38.2 | 23.5 | 34.5 | |
| US |
|
Danaher Corp
NYSE:DHR
|
187.7B USD | 4.3 | 23.3 | 16.9 | 20.8 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
43.9B USD | 6.5 | 35.5 | 28.3 | 34.1 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
42.5B USD | 2.8 | 31.3 | 16.9 | 26.2 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
37.9B CHF | 5.6 | 58 | 19.9 | 29.2 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
56T KRW | 15.2 | 65.3 | 34.4 | 49.6 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
32.5B USD | 8.6 | 41.2 | 28.5 | 31.7 | |
| US |
|
West Pharmaceutical Services Inc
NYSE:WST
|
26.6B USD | 9.1 | 46.7 | 32.5 | 39.4 | |
| IE |
|
ICON PLC
NASDAQ:ICLR
|
26.1B USD | 3.2 | 38.2 | 17.2 | 26.4 | |
| US |
|
Waters Corp
NYSE:WAT
|
20.8B USD | 7.2 | 34.5 | 23.2 | 28.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
